Q1 2016 Holdings
Filed 2016-05-16 | 42 holdings | $157.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $49.8M | 2,627,719 | 31.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $40.1M | 2,161,366 | 25.4% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $27.0M | 1,272,048 | 17.1% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $17.9M | 2,300,481 | 11.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $8.8M | 486,557 | 5.6% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $8.5M | 2,989,795 | 5.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $5.0M | 170,000 | 3.2% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $98.4K | 7,088,651 | 0.1% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $92.9K | 12,033,220 | 0.1% |
| Axovant Sciences LTD | COM | G0750W104 | $57.4K | 5,000,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $43.7K | 3,178,854 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $38.6K | 4,531,714 | 0.0% |
| Avexis Inc | COM | 05366U100 | $37.1K | 1,361,582 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $22.6K | 2,451,237 | 0.0% |
| Arena Pharmaceutical S Inc | COM | 040047102 | $18.4K | 9,364,105 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $17.5K | 1,292,940 | 0.0% |
| Celator Pharmaceuticals Inc | COM | 15089R102 | $15.6K | 1,414,114 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $14.9K | 1,691,977 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $14.9K | 1,174,219 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $13.4K | 2,212,036 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $13.2K | 498,159 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $13.0K | 2,428,571 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $12.6K | 1,626,931 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $12.3K | 2,690,702 | 0.0% |
| Dimension Therapeutics Inc | COM | 25433V105 | $12.1K | 1,548,033 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $11.5K | 3,032,911 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $10.4K | 1,575,000 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $7.5K | 783,520 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $7.2K | 1,045,119 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $6.6K | 1,064,217 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $4.9K | 2,389,700 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $4.9K | 291,700 | 0.0% |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | $4.8K | 507,191 | 0.0% |
| Pronai Therapeutics Inc | COM | 74346L101 | $4.1K | 604,982 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $3.3K | 236,059 | 0.0% |
| Arca Biopharma Inc | COM PAR$.001 | 00211Y407 | $2.7K | 778,211 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $2.6K | 257,721 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $2.6K | 612,863 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $2.0K | 144,671 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.0K | 56,442 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $252 | 81,239 | 0.0% |
| Ampliphi Biosciences Corp | COM NEW | 03211P202 | $211 | 53,600 | 0.0% |